{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:32:22Z","timestamp":1785367942562,"version":"3.55.0"},"reference-count":18,"publisher":"S. Karger AG","issue":"4","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroepidemiology"],"published-print":{"date-parts":[[2022]]},"abstract":"<jats:p>&lt;b&gt;&lt;i&gt;Introduction:&lt;\/i&gt;&lt;\/b&gt; We estimated the point prevalence of progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) at regional and national levels in Scotland, UK, as there are few high-quality prevalence studies of these conditions. &lt;b&gt;&lt;i&gt;Methods:&lt;\/i&gt;&lt;\/b&gt; Nationally, multiple methods of case ascertainment were used including clinician and nurse specialist referral, searches of ICD-10 diagnostic coding in routinely collected electronic health data (Scottish Morbidity Record), and patient self-referral. In one region, we also searched GP databases and unselected hospital correspondence. Cases were verified by clinical examination or medical record review. National and regional total and age-sex-stratified crude prevalence rates on December 31, 2018, were calculated. &lt;b&gt;&lt;i&gt;Results:&lt;\/i&gt;&lt;\/b&gt; The regional crude point prevalence was 4.28 per 100,000 (95% CI 2.90, 6.31) for PSP and 2.05 per 100,000 (95% CI 1.17, 3.59) for CBS. The national crude prevalence rates were lower due to the greater reliance on passive case ascertainment. There were no clear sex differences. At a national level, the peak crude prevalence rate for both PSP and CBS was in the 70\u201379 age group. &lt;b&gt;&lt;i&gt;Discussion:&lt;\/i&gt;&lt;\/b&gt; The prevalence rates of PSP and CBS were similar to previous estimates with little change over the past 20 years. <\/jats:p>","DOI":"10.1159\/000525334","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T21:00:36Z","timestamp":1654203636000},"page":"291-297","source":"Crossref","is-referenced-by-count":10,"title":["Prevalence of Progressive Supranuclear Palsy and Corticobasal Syndrome in Scotland"],"prefix":"10.1159","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0994-3561","authenticated-orcid":false,"given":"Diane M.A.","family":"Swallow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6622-7839","authenticated-orcid":false,"given":"Carl E.","family":"Counsell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"127","published-online":{"date-parts":[[2022,6,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.12581"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/124.7.1438"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.47.1.1"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31827f0fd1"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-015-0034-5"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(99)04137-9"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002638"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2018.03.030"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.49.2.426"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2007.00991.x"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.38.7.1031"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20149"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.557"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2010.01442.x"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2004.05.119"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1159\/000502863"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1179\/1743132815Y.0000000020"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62291-X"}],"container-title":["Neuroepidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/525334","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/525334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T15:03:45Z","timestamp":1745420625000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000525334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,9,2]]},"published-print":{"date-parts":[[2022,9,6]]}},"URL":"https:\/\/doi.org\/10.1159\/000525334","archive":["Portico"],"relation":{},"ISSN":["0251-5350","1423-0208"],"issn-type":[{"value":"0251-5350","type":"print"},{"value":"1423-0208","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]}}}